共 17 条
[1]
Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
[J].
SEMINARS IN NUCLEAR MEDICINE,
2010, 40 (02)
:122-135
Goldsmith, Stanley J.
.
[2]
Improving the efficacy of radioimmunotherapy for non‐Hodgkin lymphomas.[J].M. Corinna A.Palanca‐Wessels;Oliver W.Press.Cancer.2010, S4
[3]
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.[J]..Cancer.2010, S4
[4]
Immunogenicity of iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients
[J].
CANCER IMMUNOLOGY IMMUNOTHERAPY,
2008, 57 (05)
:677-684
Wang, Hui
;
Cao, Chuanping
;
Li, Beilei
;
Chen, Shaoliang
;
Yin, Jun
;
Shi, Jing
;
Ye, Dan
;
Tao, Qun
;
Hu, Peisheng
;
Epstein, Alan
;
Ju, Dianwen
.
[5]
Quality of life evolution after lung cancer surgery: A prospective study in 100 patients
[J].
LUNG CANCER,
2007, 56 (03)
:423-431
Balduyck, B.
;
Hendriks, J.
;
Lauwers, P.
;
Van Schil, P.
.
[6]
Updated Results of a Phase III Trial Comparing Ibritumomab Tiuxetan with Rituximab in Previously Treated Patients with Non-Hodgkin's Lymphoma.[J].Angelia D. Gibson;Dan L. Longo;Vinay K. Jain.Clinical Lymphoma.2002, 2
[7]
Quality of life in lung cancer patients.[J].Ali Montazeri;Robert Milroy;David Hole;James McEwen;Charles R. Gillis.Lung Cancer.2001, 2
[8]
A phase I safety and imaging study using radiofrequency ablation (RFA) followed by 131I-chTNT-1/B radioimmutherapy adjuvant treatment of hepatic-metastases..Anderson PM;Wiseman GA;Bradley D; et al;.Cancer Ther.2003, 01
[9]
[10]